Articles From: Cyclacel Reports Updated Phase 2 Survival Data of Sapacitabine for MDS to CB&I Announces The Commercialization Of The AlkyClean® Solid Acid Alkylation Process


2013/4/30
BERKELEY HEIGHTS, N.J., April 30, 2013 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC) (Nasdaq:CYCCP) (Cyclacel or the Company), announced updated median overall survival data from an ongoing, multicenter, Phase 2 randomized trial of oral sapacitabine capsules, the Company's lead product candidate, in older patients with intermediate-2 or high-risk myelodysplastic syndromes (MDS) after treatment failure of front-line hypomethylating agents, such as azacitidine (Vidaza®) and/or decitabine (Dacogen®). Median overall survival to date for all 63 patients treated is approximately 9 months.
Sign-up for Cyclacel Reports Updated Phase 2 Survival Data of Sapacitabine for MDS investment picks
2013/4/30
Amedisys, Inc. (NASDAQ: AMED) , a leading home health and hospice company, today reported its financial results for the first quarter ended March 31, 2013.
Sign-up for Amedisys Reports First Quarter Financial Results and Updates 2013 Guidance investment picks
2013/4/30
CAMBRIDGE, Mass., April 30, 2013 (GLOBE NEWSWIRE) -- Aegerion Pharmaceuticals, Inc. (Nasdaq:AEGR) , a biopharmaceutical company dedicated to the development and commercialization of innovative, life-altering therapies for patients with debilitating, often fatal, rare diseases, announced its financial results and business highlights for the first-quarter of 2013.
Sign-up for Aegerion Pharmaceuticals Announces First-Quarter 2013 Financial Results investment picks
2013/4/30
bebe stores, inc.
Sign-up for bebe stores, inc. Promotes Liyuan Woo to Chief Financial Officer investment picks
2013/4/30
Pfizer Inc. (NYSE: PFE) reported financial results for first-quarter 2013 and updated certain components of its 2013 financial guidance to reflect the impact of recent changes in foreign exchange rates and the initial public offering (IPO) of a 19.8% ownership interest in Zoetis (1) completed on February 6, 2013, among other factors.
Sign-up for Pfizer Reports First-Quarter 2013 Results investment picks
2013/4/30
http://media.marketwire.com/attachments/201209/51143_calliduscloud_logo.gif http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1011798&ProfileId=051205&sourceType=1 PLEASANTON, CA --
Sign-up for CallidusCloud Announces New Board Member investment picks
2013/4/30
SANTA ANA, Calif.
Sign-up for idOnDemand High Assurance 'Identity as a Service' Solution Selected for $2 Million Global Roll Out investment picks
2013/4/30
The Board of Directors of The Hershey Company (NYSE: HSY) today announced quarterly dividends of $0.42 on the Common Stock and $0.38 on the Class B Common Stock.
Sign-up for Hershey Declares Quarterly Dividends investment picks
2013/4/30
HOPKINSVILLE, Ky.
Sign-up for HopFed Bancorp, Inc. Reports First Quarter Results investment picks
2013/4/30
JASPER, Ind., April 30, 2013 (GLOBE NEWSWIRE) -- German American Bancorp, Inc. (Nasdaq:GABC) reported increased quarterly earnings and continued balance sheet growth during the first quarter of 2013, as compared to the same quarter of the prior year.
Sign-up for German American Bancorp, Inc. Reports Increase in Quarterly Earnings investment picks
2013/4/30
Office Depot, Inc. (NYSE: ODP) , a leading global provider of office supplies and services, today announced results for the fiscal quarter ended March 30, 2013.
Sign-up for Office Depot Announces First Quarter 2013 Results investment picks
2013/4/30
WIESBADEN, Germany , April 30, 2013 /PRNewswire/ -- Medical device manufacturer OrbusNeich Medical Inc. and its subsidiary, OrbusNeich Medical GmbH (collectively, "OrbusNeich") today announced that it has obtained a preliminary injunction from the Dusseldorf Regional Court in patent infringement proceedings against Boston Scientific Corporation (NYSE: BSX) and its German distribution subsidiary (collectively, "Boston Scientific"). In late February, OrbusNeich filed suit in the German Court charging Boston Scientific with infringing two patents covering certain novel stent designs developed by OrbusNeich.
Sign-up for OrbusNeich obtains preliminary injunction in patent infringement proceedings in Germany against Boston Scientific investment picks
2013/4/30
http://media.marketwire.com/attachments/201108/10048_CobraLogo-Black.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1011648&ProfileId=051205&sourceType=1 CHICAGO, IL --
Sign-up for Cobra Electronics Named as Finalist in 2013 CTIA E-Tech Awards investment picks
2013/4/30
MOUNTAIN VIEW, Calif., April 30, 2013 (GLOBE NEWSWIRE) -- VIVUS, Inc. (Nasdaq:VVUS) today announced the appointment of Robert N.
Sign-up for VIVUS Appoints Robert N. Wilson to Board of Directors investment picks
2013/4/30
MINNEAPOLIS , April 30, 2013 /PRNewswire/ -- Techne Corporation's (NASDAQ:TECH) financial results for the third quarter and nine months ended March 31, 2013 include the following highlights: Third quarter earnings were $33.1 million or $0.90 per diluted share.
Sign-up for Techne Corporation Releases Unaudited Third Quarter And Nine Month Fiscal Year 2013 Results investment picks
2013/4/30
MINNEAPOLIS , April 30, 2013 /PRNewswire/ -- Techne Corporation (NASDAQ:TECH) announced that its Board of Directors has decided to pay a dividend of $0.30 per share for the quarter ended March 31 , 2013.
Sign-up for Techne Corporation Declares Dividend investment picks
2013/4/30
Oshkosh Corporation (NYSE: OSK) today reported fiscal 2013 second quarter net income of $85.4 million, or $0.96 per diluted share, compared to $42.8 million, or $0.47 per diluted share, in the second quarter of fiscal 2012.
Sign-up for Oshkosh Corporation Reports Fiscal 2013 Second Quarter Results investment picks
2013/4/30
G&K Services, Inc. (NASDAQ: GK) today reported operating results for the third quarter of its fiscal year 2013, which ended on March 30, 2013.
Sign-up for G&K Services Reports Fiscal 2013 Third Quarter Results investment picks
2013/4/30
Clean Power Finance , the online marketplace for distributed solar financing and provider of solar sales and design software, today announced the appointment of Michael Pope as chief financial officer (CFO). Michael brings deep experience managing the financial strength of fast-growing public and private companies to Clean Power Finance.
Sign-up for Michael Pope Joins Clean Power Finance as Chief Financial Officer investment picks
2013/4/30
Xylem Inc. (NYSE: XYL) , a leading global water technology company dedicated to solving the world’s most challenging water issues, today reported first quarter 2013 net income of $41 million, or $0.22 per share.
Sign-up for Xylem Inc. reports first quarter 2013 results, affirms full-year guidance investment picks
2013/4/30
LEXINGTON, Mass., April 30, 2013 (GLOBE NEWSWIRE) -- Curis, Inc. (Nasdaq:CRIS) , an oncology-focused company seeking to develop next generation targeted drug candidates for cancer treatment, today reported its financial results for the first quarter ended March 31, 2013.
Sign-up for Curis Reports First Quarter 2013 Financial Results investment picks
2013/4/30
http://media.marketwire.com/attachments/201211/102974_EvolvinglogoR.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1011655&ProfileId=051205&sourceType=1 ENGLEWOOD, CO --
Sign-up for Evolving Systems Sets Date for 2013 First Quarter Financial Results News Release and Conference Call investment picks
2013/4/30
USA Technologies, Inc .
Sign-up for USA Technologies Announces Conference Call to Discuss Third Quarter, Fiscal Year 2013 Results investment picks
2013/4/30
Company Now Offers Complete Power Train Solutions for FPGAs, DSPs, CPUs, and MCUs used in Aerospace Applications ALISO VIEJO, Calif.
Sign-up for Microsemi Expands Power Management Portfolio With New Radiation-hardened Isolated DC-DC Converters investment picks
2013/4/30
SAN DIEGO, April 30, 2013 (GLOBE NEWSWIRE) -- Mitek Systems, Inc. (Nasdaq:MITK) ( www.miteksystems.com ), a leading mobile imaging software solutions provider, today announced that it will release its financial results for the second quarter of fiscal 2013, ended March 31, 2013, after the market closes on Tuesday, May 7, 2013.
Sign-up for Mitek to Report Second Quarter Fiscal 2013 Financial Results on May 7, 2013 investment picks
2013/4/30
Ritchie Bros.
Sign-up for Ritchie Bros. Auctioneers Announces First Quarter Results investment picks
2013/4/30
VANCOUVER , April 30, 2013 /PRNewswire/ - Ritchie Bros.
Sign-up for Ritchie Bros. Auctioneers Announces First Quarter Results investment picks
2013/4/30
Cobalt International Energy, Inc. (“Cobalt”) (NYSE:CIE) today announced a net loss of $128.1 million, or $0.31 per basic and diluted share for the first quarter of 2013, compared to a net loss of $36.5 million, or $0.09 per basic and diluted share, for the first quarter of 2012.
Sign-up for Cobalt International Energy, Inc. Announces First Quarter 2013 Results and Provides Operational Update on Its Gulf of Mexico and West Africa Drilling Operations investment picks
2013/4/30
THE WOODLANDS, Texas , April 30, 2013 /PRNewswire/ -- CB&I (NYSE: CBI) has been awarded a contract by Shandong Wonfull Petrochemical Group Co., Ltd.
Sign-up for CB&I Announces The Commercialization Of The AlkyClean® Solid Acid Alkylation Process investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Cyclacel Reports Updated Phase 2 Survival Data of Sapacitabine for MDS to CB&I Announces The Commercialization Of The AlkyClean® Solid Acid Alkylation Process
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity